Aktive Positionen von Mads Hald Andersen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Direktor/Vorstandsmitglied | - | - |
| Gründer | - | - | |
| Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Mads Hald Andersen
Ehemalige bekannte Positionen von Mads Hald Andersen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHOSA ONCOLOGY AB | Gründer | 01.11.2015 | - |
| IO BIOTECH, INC. | Gründer | 01.12.2014 | - |
Survac ApS
 Survac ApS Pharmaceuticals: OtherHealth Technology Survac ApS specializes in the development of peptide based therapeutic cancer vaccines. It offers the vaccine candidates for licensing and collaboration agreements. The company's vaccine is being examined in clinical phase I & II trials. Survac was founded in 2003 and is located in Hellerup, Denmark | Verwaltungsdirektor | - | - |
Ausbildung von Mads Hald Andersen
| University of Copenhagen | Doctorate Degree |
Statistik
International
| Dänemark | 5 |
| Schweden | 2 |
Operativ
| Founder | 3 |
| Chief Administrative Officer | 1 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IO BIOTECH, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Survac ApS
Survac ApS Pharmaceuticals: OtherHealth Technology Survac ApS specializes in the development of peptide based therapeutic cancer vaccines. It offers the vaccine candidates for licensing and collaboration agreements. The company's vaccine is being examined in clinical phase I & II trials. Survac was founded in 2003 and is located in Hellerup, Denmark | Health Technology |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Health Technology |
- Börse
- Insiders
- Mads Hald Andersen
- Erfahrung